Statement Of Changes In Equity [Abstract]

Biocartis Group NV - Filing #3122955

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	30,284 EUR	—	—	5,843 EUR	631,722 EUR	7,502 EUR	443,363 EUR	220,302 EUR	30,284 EUR	—	—	—	526,405 EUR	—	33,897 EUR	—	5,572 EUR	—	33,897 EUR	711,874 EUR	6,862 EUR	220,657 EUR	—	—	455,343 EUR	36,824 EUR	220,657 EUR	5,153 EUR	6,102 EUR	711,874 EUR	36,824 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	65,381 EUR	65,381 EUR	—	—	—	—	—	—	—	65,381 EUR	—	—	71,472 EUR	—	—	—	—	—	—	—	—	71,472 EUR	71,472 EUR	—	—	—	—	—	—	—
Comprehensive income	—	65,274 EUR	65,003 EUR	—	—	—	—	—	—	271,000 EUR	65,274 EUR	—	—	71,481 EUR	—	419,000 EUR	—	—	—	—	—	—	71,481 EUR	71,062 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	640,000 EUR	—	—	—	—	—	—	—	—	640,000 EUR	640,000 EUR	—	760,000 EUR	—	—	—	760,000 EUR	—	—	—	—	760,000 EUR	—	—	—	—	—	—	—	—